PUBLISHER: IMARC | PRODUCT CODE: 1820121
PUBLISHER: IMARC | PRODUCT CODE: 1820121
The global catheters market size reached USD 23.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 44.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.88% during 2025-2033.
A catheter is a thin tube inserted into the patient's body for therapeutic and diagnostic applications. It is manufactured using medical-grade materials, such as plastic, silicone rubbers, latex, polyvinyl chloride (PVC) and nylon. Some of the commonly available variants include cardiovascular, neurovascular, urinary, intravenous and specialty catheters. They are used to deliver medicines and gases into the bodies and are also used in acute care facilities to monitor and manage drainage of bodily fluids, such as urine, during surgery and post-operative recovery. As a result, catheters find extensive applications in the treatment of various neurovascular, urological and cardiovascular disorders.
The increasing prevalence of urological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, the rising geriatric population, which is more susceptible to such ailments and the increasing preference for minimally invasive surgeries (MI) are providing a thrust to the market growth. These catheters are also widely used in hospitals, clinics and other healthcare centers for electrophysiological procedures that use catheters to insert wire electrodes to measure electrical activity in the blood vessels entering the heart. Additionally, various technological advancements, such as the utilization of robot-assisted surgical interventions, are acting as other growth-inducing factors. In line with this, the manufacturing of anti-microbial catheters with silver ion coatings to minimize the incidence of catheter-associated infections and thrombosis, which is favoring the market growth. Other factors, including rising expenditure capacities of the masses on medical procedures, along with significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Coloplast Corporation, ConvaTec Group PLC, Edwards Lifesciences Corporation, Hollister Incorporated, Johnson & Johnson, Medtronic plc, Stryker Corporation and Teleflex Incorporated.